SEC ownership of TEVA PHARMACEUTICAL INDUSTRIES LTD

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000818686.

Comparable stake leader

Harel Insurance Investments & Financial Services Ltd.

Disclosed value leader

Harel Insurance Investments & Financial Services Ltd.

Comparable rows

5/50

Latest evidence

05 Nov 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
5 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Harel Insurance Investments & Financial Services Ltd.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
05 Nov 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000818686
Issuer location
Tel Aviv

Ownership snapshot

Top shareholders of TEVA PHARMACEUTICAL INDUSTRIES LTD (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Harel Insurance Investmen...
Disclosed value leader
Harel Insurance Investmen...
Comparable rows
5/50
Latest evidence
05 Nov 2026
13D/G 13F 3/4/5 Lead comparable stake: 6% 45 rows are not safely comparable across share classes. 13D/G row: Harel Insurance Investments & Financial Services Ltd. Showing 1-8 of 50 holder rows.

Quick read

Harel Insurance Investments & Financial Services Ltd. leads the comparable SEC ownership view at 6%.

5 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Harel Insurance Investments & Financial Services Ltd.'s linked filing trail.
Comparable ownership Top 5
Harel Insurance Investments & Fin... 6%
Migdal Insurance & Financial Hold... 5.4%
MENORA MIVTACHIM HOLDINGS LTD. 5%
Phoenix Financial Ltd. 4.8%
FMR LLC 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Harel Insurance Investments & Financial Services Ltd.
13D/G
6%
Reported 13D/G · 30 Sep 2026
$2,899,117,335
70,418,201 shares
-$78,525,764 30 Sep 2026
Migdal Insurance & Financial Holdings Ltd.
13D/G 13F
Company
5.4%
Reported 13D/G · 31 Dec 2025
$2,022,794,213
61,689,363 shares
$0 31 Dec 2025
MENORA MIVTACHIM HOLDINGS LTD.
13D/G
5%
Reported 13D/G · 05 Nov 2026
$2,305,097,824
58,209,541 shares
+$32,248,973 05 Nov 2026
Phoenix Financial Ltd.
13D/G 13F
Company
4.8%
Reported 13D/G · 04 Nov 2026
$2,328,169,625
56,550,149 shares
$0 04 Nov 2026
FMR LLC
13D/G
2.1%
Reported 13D/G · 30 Sep 2025
—
24,641,361 shares
-$561,363,714 30 Sep 2025
WCM INVESTMENT MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$1,682,110,760
42,253,473 shares
— 30 Sep 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$1,291,590,182
32,515,751 shares
— 30 Sep 2026
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$764,640,598
19,309,106 shares
— 30 Sep 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$125,649,337.

Buys
$0
Insiders: 0
Sells
$125,649,337
Insiders: 15
Net
-$125,649,337
Shares: -3,646,084
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 3,646,084
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 814,064 $0 $33,242,786 -$33,242,786
3-6 0 195,922 $0 $6,718,825 -$6,718,825
6-9 0 1,688,031 $0 $56,107,868 -$56,107,868
9-12 0 948,067 $0 $29,579,857 -$29,579,857

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 38 reporting-owner rows connected to TEVA PHARMACEUTICAL INDUSTRIES LTD. Open a relationship link for the CIK-to-CIK filing trail.

Rows
38
Largest Forms 3/4/5 holder
Amir Elstein
Net 12M change
-$125.65MFull value: -$125,649,338 · USD · 12-month change
Latest report
15 Nov 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Amir Elstein Director $63,807,864 Mixed 05 Jun 2026
Richard D. Francis President and CEO $39,175,764 -$41,822,264 -52% Filing P/S 10 Nov 2026
Kare Schultz President and CEO, Director $15,013,641 Mixed 01 Nov 2022
Sol J. Barer Director $13,494,091 Mixed 05 Jun 2026
Eric A. Hughes Executive Vice President, Global R&D and Chief Medical Officer. $4,703,929 -$4,173,498 -47% Filing P/S 03 Aug 2026
Ronit Satchi-Fainaro Director $4,171,478 -$15,459 -0.37% Filing P/S 21 Aug 2026
Roberto A. Mignone Director $4,059,061 -$17,998,952 -82% Mixed 19 Sep 2026
Gerald M. Lieberman Director $3,920,087 Mixed 05 Jun 2026
Rosemary A. Crane Director $3,847,498 Mixed 05 Jun 2026
Perry D. Nisen Director $3,608,586 Mixed 05 Jun 2026
Mark Sabag Executive Vice President, International Markets Commercial $3,564,827 -$17,049,962 -83% Filing P/S 12 Nov 2026
Tal Zvi Zaks Director $2,553,793 -$593 -0.02% Filing P/S 05 Aug 2026
Richard Daniell EVP, Europe Commercial $2,386,386 -$14,007,234 -85% Filing P/S 09 Nov 2026
Christine Fox EVP, U.S. Commercial $2,247,375 -$1,996,445 -47% Filing P/S 30 Apr 2026
Eliyahu Sharon Kalif EVP, Chief Financial Officer $2,237,374 -$20,725,392 -90% Filing P/S 11 Jun 2026
Eric Drape Executive VP Global Operations $1,972,100 Mixed 05 Mar 2024
Sven Dethlefs EVP, North America Commercial $1,609,736 Mixed 06 Mar 2023
Janet S. Vergis Director $1,254,345 Mixed 05 Jun 2025
Evan Lippman EVP, Business Development $935,985 -$2,162,658 -70% Filing P/S 17 Aug 2026
Dov Bergwerk Interim Chief Legal Officer $804,394 -$1,095,567 -58% Median 15 Nov 2026

Recent insider transactions for TEVA PHARMACEUTICAL INDUSTRIES LTD

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Dov Bergwerk TEVA Ordinary Shares Options Exercise 70.1% 8,370 20,313 15 Nov 2026 Direct
Dov Bergwerk TEVA Restricted Share Units Options Exercise -50% -8,370 8,372 15 Nov 2026 Direct
Mark Sabag TEVA Ordinary Shares Sale -35.6% -$1,973,544 $44.14 -44,710 80,760 12 Nov 2026 Direct
Mark Sabag TEVA Ordinary Shares Options Exercise 55.4% 44,710 125,470 12 Nov 2026 Direct
Mark Sabag TEVA Stock Options (right to buy) Options Exercise -100% -44,710 0 12 Nov 2026 Direct
Richard Daniell TEVA Ordinary Shares Sale -26.4% -$856,154 $42.80 -20,003 55,755 11 Nov 2026 Direct
Richard Daniell TEVA Ordinary Shares Options Exercise 35.9% 20,003 75,758 11 Nov 2026 Direct
Richard Daniell TEVA Stock Options (right to buy) Options Exercise -100% -20,003 0 11 Nov 2026 Direct
Richard D. Francis TEVA Ordinary Shares Sale -21.2% -$10,559,175 $42.24 -250,000 927,529 10 Nov 2026 Direct
Dov Bergwerk TEVA Restricted Share Units Award 9,433 9,433 10 Nov 2026 Direct
David J. Brailer TEVA Restricted Share Units Award 3,326 3,326 10 Nov 2026 Direct
Richard Daniell TEVA Ordinary Shares Sale -31% -$1,072,790 $42.91 -25,000 55,755 09 Nov 2026 Direct
Richard Daniell TEVA Ordinary Shares Options Exercise 44.8% 25,000 80,755 09 Nov 2026 Direct
Richard Daniell TEVA Stock Options (right to buy) Options Exercise -55.6% -25,000 20,003 09 Nov 2026 Direct
Amir Weiss TEVA Ordinary Shares Sale -83% -$744,049 $43.04 -17,289 3,537 09 Nov 2026 Direct
Amir Weiss TEVA Ordinary Shares Options Exercise 59.3% 7,755 20,826 09 Nov 2026 Direct
Amir Weiss TEVA Stock Options (right to buy) Options Exercise -100% -7,755 0 09 Nov 2026 Direct
Mark Sabag TEVA Ordinary Shares Sale -36.3% -$1,928,729 $41.93 -46,000 80,760 05 Nov 2026 Direct
Mark Sabag TEVA Ordinary Shares Options Exercise 57% 46,000 126,760 05 Nov 2026 Direct
Mark Sabag TEVA Stock Options (right to buy) Options Exercise -50.7% -46,000 44,710 05 Nov 2026 Direct
Dov Bergwerk TEVA Ordinary Shares Sale -68.7% -$1,095,567 $41.72 -26,260 11,943 04 Nov 2026 Direct
Dov Bergwerk TEVA Ordinary Shares Options Exercise 823.7% 26,260 29,448 04 Nov 2026 Direct
Dov Bergwerk TEVA Stock Options (right to buy) Options Exercise -100% -26,260 0 04 Nov 2026 Direct
Brian P. Savage TEVA Ordinary Shares Sale -46.4% -$285,215 $38.85 -7,342 8,500 18 Sep 2026 Direct
Brian P. Savage TEVA Ordinary Shares Options Exercise 39.7% 4,503 15,842 18 Sep 2026 Direct
Brian P. Savage TEVA Stock Options (right to buy) Options Exercise -100% -4,503 0 18 Sep 2026 Direct
Roberto Mignone TEVA Ordinary Shares Sale -100% -$14,356,802 $39.06 -367,600 0 18 Sep 2026 [see footnote]
Amir Weiss TEVA Ordinary Shares Options Exercise 19.1% 2,500 15,571 21 Aug 2026 Direct
Amir Weiss TEVA Ordinary Shares Sale -42% -$355,301 $37.62 -9,445 13,071 21 Aug 2026 Direct
Amir Weiss TEVA Stock Options (right to buy) Options Exercise -25% -2,500 7,502 21 Aug 2026 Direct
Ronit Satchi-Fainaro TEVA Ordinary Shares Sale -0.37% -$15,459 $37.25 -415 111,986 21 Aug 2026 Direct
Evan Lippman TEVA Ordinary Shares Sale -42.1% -$680,291 $36.57 -18,600 25,591 17 Aug 2026 Direct
Tal Zvi Zaks TEVA Ordinary Shares Sale -0.02% -$593 $34.87 -17 73,247 05 Aug 2026 Direct
Placid Jover TEVA Ordinary Shares Sale -65.4% -$447,351 $34.88 -12,827 6,774 03 Aug 2026 Direct
Placid Jover TEVA Ordinary Shares Options Exercise 189.4% 12,827 19,601 03 Aug 2026 Direct
Placid Jover TEVA Restricted Share Units Options Exercise -33.3% -12,827 25,657 03 Aug 2026 Direct
Eric A. Hughes TEVA Ordinary Shares Sale -15.9% -$892,051 $34.88 -25,578 134,877 03 Aug 2026 Direct
Eric A. Hughes TEVA Ordinary Shares Options Exercise 49% 52,744 160,455 03 Aug 2026 Direct
Eric A. Hughes TEVA Restricted Share Units Options Exercise -100% -52,744 0 03 Aug 2026 Direct
Matthew Shields TEVA Ordinary Shares Sale -100% -$321,547 $32.19 -9,989 0 18 Jun 2026 Direct
Eliyahu Sharon Kalif TEVA Ordinary Shares Sale -61.9% -$3,633,308 $34.10 -106,563 65,621 11 Jun 2026 Direct
Sol J. Barer TEVA Ordinary Shares Options Exercise 5.1% 21,739 448,011 05 Jun 2026 Direct
Sol J. Barer TEVA Restricted Share Units Options Exercise -100% -21,739 0 05 Jun 2026 Direct
Chen Lichtenstein TEVA Ordinary Shares Options Exercise 301.7% 14,492 19,296 05 Jun 2026 Direct
Chen Lichtenstein TEVA Restricted Share Units Options Exercise -100% -14,492 0 05 Jun 2026 Direct
Rosemary A. Crane TEVA Ordinary Shares Options Exercise 12.8% 14,492 127,739 05 Jun 2026 Direct
Rosemary A. Crane TEVA Restricted Share Units Options Exercise -100% -14,492 0 05 Jun 2026 Direct
Amir Elstein TEVA Ordinary Shares Options Exercise 0.69% 14,492 2,118,455 05 Jun 2026 Direct
Amir Elstein TEVA Restricted Share Units Options Exercise -100% -14,492 0 05 Jun 2026 Direct
Gerald M. Lieberman TEVA Ordinary Shares Options Exercise 12.5% 14,492 130,149 05 Jun 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .